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Abstract
AIM
To evaluate the presence of submucosal and myen-
teric plexitis and its role in predicting postoperative 
recurrence.
METHODS
Data from all patients who underwent Crohn’s disease 
(CD)-related resection at the University of Szeged, 
Hungary between 2004 and 2014 were analyzed retro-
spectively. Demographic data, smoking habits, previous 
resection, treatment before and after surgery, resection 
margins, neural fiber hyperplasia, submucosal and 
myenteric plexitis were evaluated as possible predictors 
of postoperative recurrence. Histological samples were 
analyzed blinded to the postoperative outcome and the 
clinical history of the patient. Plexitis was evaluated 
based on the appearance of the most severely inflamed 
ganglion or nerve bundle. Patients underwent regular 
follow-up with colonoscopy after surgery. Postoperative 
Retrospective Study
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recurrence was defined on the basis of endoscopic and 
clinical findings, and/or the need for additional surgical 
resection. 
RESULTS
One hundred and four patients were enrolled in the 
study. Ileocecal, colonic, and small bowel resection were 
performed in 73.1%, 22.1% and 4.8% of the cases, 
respectively. Mean disease duration at the time of 
surgery was 6.25 years. Twenty-six patients underwent 
previous CD-related surgery. Forty-three point two 
percent of the patients were on 5-aminosalicylate, 20% 
on corticosteroid, 68.3% on immunomodulant, and 
4% on anti-tumor necrosis factor-alpha postoperative 
treatment. Postoperative recurrence occurred in 61.5% 
of the patients; of them 39.1% had surgical recurrence. 
92.2% of the recurrences developed within the first five 
years after the index surgery. Mean disease duration 
for endoscopic relapse was 2.19 years. The severity 
of submucosal plexitis was a predictor of the need for 
second surgery (OR = 1.267, 95%CI: 1.000-1.606, P  = 
0.050). Female gender (OR = 2.21, 95%CI: 0.98-5.00, 
P  = 0.056), stricturing disease behavior (OR = 3.584, 
95%CI: 1.344-9.559, P  = 0.011), and isolated ileal 
localization (OR = 2.671, 95%CI: 1.033-6.910, P  = 
0.043) were also predictors of postoperative recurrence. 
No association was revealed between postoperative 
recurrence and smoking status, postoperative prophy-
lactic treatment and the presence of myenteric plexitis 
and relapse.
CONCLUSION
The presence of severe submucosal plexitis with lym-
phocytes in the proximal resection margin is more likely 
to result in postoperative relapse in CD. 
Key words: Submucosal plexitis; Postoperative recur-
rence; Crohn’s disease; Stricturing disease behavior; 
Isolated ileal disease
© The Author(s) 2017. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: This is a retrospective study to evaluate 
the presence of submucosal and myenteric plexitis 
and its role in predicting postoperative recurrence 
(POR) in Crohn’s disease. Demographic data, smoking 
habits, previous resection, treatment before and after 
surgery, and histological findings were evaluated as 
possible predictors of POR. We found that the severity 
of submucosal plexitis was a predictor of the need for 
second surgery. Other predictors of POR were female 
gender, stricturing disease behavior, and isolated ileal 
localization. Our results did not confirm the hypothesis 
that myenteric plexitis can be predictive of postoperative 
relapse.
Milassin Á, Sejben A, Tiszlavicz L, Reisz Z, Lázár G, Szűcs M, 
Bor R, Bálint A, Rutka M, Szepes Z, Nagy F, Farkas K, Molnár T. 
Analysis of risk factors - especially different types of plexitis - for 
postoperative relapse in Crohn’s disease. World J Gastrointest 
Surg 2017; 9(7): 167-173  Available from: URL: http://www.
wjgnet.com/1948-9366/full/v9/i7/167.htm  DOI: http://dx.doi.
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INTRODUCTION
Surgery is not curative in Crohn’s disease (CD), hence 
postoperative recurrence still remains a significant 
problem in the treatment of CD. More than 70% of all 
patients with CD require surgery in the course of their 
disease. A second surgery is required in 34%-53% 
of the cases; the highest recurrence rate has been 
observed in the ileocolic disease location[1]. Farmer et 
al[2] also demonstrated that operative incidence was the 
highest (91.5%) among patients with ileocolic disease. 
Therefore it is important to identify the predictors of 
postoperative recurrence in order to optimize treatment 
and surveillance after surgery. Currently conflicting data 
are available on the different risk factors. The IBSEN 
study group found that the probability of surgery was 
37.9% in a 10-year follow-up. Terminal ileal location, 
stricturing, penetrating behavior, and age younger than 
40 years at diagnosis were independent risk factors of 
subsequent surgery[3]. A large meta-analysis of 2962 
patients with CD revealed that smoking significantly 
increases the risk of clinical and surgical recurrence. 
This high risk of postoperative relapse and reoperation 
is significantly reduced if a patient quits smoking[4]. A 
recently published study only identified preoperative 
steroid use as a risk factor for early postoperative endo-
scopic recurrence[5], while another study found a higher 
risk for postoperative endoscopic recurrence in case of 
previous use of two or more anti-tumor necrosis factor 
(TNF)-α agents[6]. 
Histological changes in the enteric nervous system 
are common in CD. The major structural abnormalities 
are irregular hypertrophy and hyperplasia of nerve 
fibers and alterations of neuronal cell bodies and 
enteric glial cells in the ganglia of the submucosal and 
myenteric plexus[7]. Ferrante et al[8] showed that the 
presence of myenteric plexitis in proximal resection 
margins of ileocolonic resection specimens is highly 
associated with postoperative CD recurrence, and 
the severity of myenteric plexitis in the proximal 
resection margin correlated with the severity of endo-
scopic recurrence[8-10]. Sokol et al[11] revealed an asso-
ciation between submucosal plexitis and early clinical 
recurrence, moreover lymphocytic plexitis in the 
proximal surgical margin was related to a higher risk 
of endoscopic or surgical recurrence after ileocolonic 
resection[12,13].
Our aim was to evaluate the frequency and pre-
dictors of postoperative recurrence and the role of 
submucosal and myenteric plexitis in predicting post-
operative recurrence on the basis of endoscopic findings 
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and/or the need for additional surgical resection. 
MATERIALS AND METHODS
Patients and data collection
Patients were selected retrospectively from the data-
base of the Department of Pathology, University of 
Szeged (Hungary). All patients who underwent CD-
related surgery between 2004 and 2014 were included 
in the study. 
Diagnosis of CD was based on clinical, endoscopic 
and histological findings. The following data were 
extracted retrospectively from the medical chart of 
each patient: Age, sex, year of the diagnosis of CD, 
phenotype of CD according to the Montréal classi-
fication[14], smoking habits, date of the CD-related 
surgery, type of the anastomosis, CD-related therapy 
before and after surgery, and the presence of post-
operative relapse. Postoperative relapse was defined 
on the basis of endoscopic and clinical findings, and/or 
the need for additional surgical resection. Patients were 
regularly followed up with colonoscopy after the surgery. 
Postoperative endoscopy findings were classified on 
the basis of the Rutgeerts score in case of ileocolonic 
resection[15]; remission was defined as Rutgeerts endo­
scopic score i0-i1, and recurrence as a score of i2-i4[15]. 
Postoperative recurrences were defined on the 
basis of the work of Ng et al[10] Clinical recurrence 
was defined as the presence of CD­related symptoms 
associated with radiologic or endoscopic findings, con­
sidered severe enough to change the current therapy 
(requires steroid treatment or an increase in existing 
treatment). Surgical recurrence was defined as a need 
for further operation (refractory to medical treatment 
or new complications developed)[10].
Pathologic examination
Histological samples were analyzed retrospectively by 
two expert pathologists, blinded to the postoperative 
outcome and the clinical history of the patient. Both rese-
ction margins (ileal and colonic margins) were investi-
gated for typical CD lesions (inflammatory infiltrates, 
granuloma, etc). Further investigations focused on the 
proximal resection margin. Special attention was given 
to the enteric nervous system, namely to the myenteric 
and submucosal plexuses. Plexitis was evaluated based 
on the appearance of the most severely inflamed 
ganglion or nerve bundle[12]. The severity of plexitis 
was graded according to the classification proposed by 
Ferrante et al[8]: Mild plexitis if the ganglion or nerve 
bundle contained 0­4 inflammatory cells (G1), moderate 
plexitis if it contained 4 to 9 cells (G2), or severe if 
containing ≥ 10 cells (G3). Evaluation was performed 
independently for each cellular type: Mast cell, plasmo-
cyte, lymphocyte, eosinophil and neutrophil cell counts 
were also evaluated[12]. Each sample was fixed in 
buffered formalin and analyzed using hematoxylin-eosin 
staining. Some examples are demonstrated in Figure 1.
Statistical analysis
The statistical analysis of the data was performed by a 
biomedical statistician using SPSS. To identify predictors 
of postoperative recurrence (clinical recurrence or 
surgical recurrence) among patients’ baseline charac-
teristics, histological findings such as severity of my-
enteric and submucosal plexitis univariable logistic 
regression analysis was used. P values < 0.05 were 
considered statistically significant. Survival was exa-
mined with the Kaplan-Meier method. 
RESULTS
Patient characteristics
One hundred and four patients with CD were enrolled 
in the study. The baseline characteristics of the patients 
are reported in Table 1. Mean age at index CD-related 
surgery was 34.8 ± 13.24 years, mean disease 
duration at the time of the index surgery was 6.25 ± 
6.12 years. 86.5% of the patients were on specific CD­
related treatment at the time of the index surgery; 
37.5% of patients were on aminosalicylates, 13.5% 
on anti-TNF-α therapy, 51% on corticosteroid, 12.5% 
on budesonide, 43.3% on azathioprine, 6.7% on 
methotrexate, and 35.6% on antibiotics. Operations 
were performed for specific reasons: abscess (20.2%), 
fistulas (13.5%), perforation (4.8%), stenosis (67.3%) 
and other (1%). Ileocecal, colonic and small bowel 
  Baseline characteristics of patients n  = 104
  Mean age at diagnosis (yr)    41.3 ± 14.047
  Mean disease duration at the time of the 
  operation (yr)
6.25 ± 6.12
  Sex
     Female  50 (48)
     Male  54 (52)
  Age at index resection (yr)
     Younger than 40     74 (71.2)
     40 and older     30 (28.8)
  Smoking history at index surgery
     Current smoker     32 (30.8)
     Never smoked     68 (65.4)
     Ex-smoker    4 (3.8)
  Montréal classification
     A1 (< 16 yr)     15 (14.4)
     A2 (between 17 and 40 yr)     71 (68.3)
     A3 (> 40 yr)     18 (17.3)
     B1 (nonstricturing, nonpenetrating)     12 (11.5)
     B2 (stricturing)  52 (50)
     B3 (penetrating)     40 (38.5)
     L1 (isolated ileal disease)  51 (49)
     L2 (isolated colonic disease)     22 (21.2)
     L3 (ileocolonic disease)     31 (29.8)
     L4 (isolated upper disease)  0 (0)
     p (perianal disease modifier)     14 (13.5)
  Type of index resection
     Ileocolonic resection     76 (73.1)
     Colonic resection     23 (22.1)
     Small bowel resection     5 (4.8) 
     Previous resection before index surgery  26 (25)
Table 1  Patient characteristics  n  (%)
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resection were performed in 73.1%, 22.1% and 
4.8% of the cases, respectively. Twenty-six patients 
had undergone previous CD-related surgery. Forty-
three point two percent of the patients were on 
5-aminosalicylate, 20% on corticosteroid, 68.3% on 
immunomodulant, and 4% on anti-TNF-α postoperative 
treatment. Postoperative recurrence occurred in 61.5% 
of the patients; of them 39.1% had surgical recurrence. 
92.2% of the recurrences developed within the first five 
years after the index surgery. Mean disease duration for 
postoperative relapse was 2.70 ± 2.11 years.
Histological findings
Typical Crohn’s lesions, such as inflammatory cell 
infiltration, architectural alterations, crypt abscesses, 
ulcers, and granulomas were detected in both resection 
margins. Typical CD lesions were found in proximal 
resection margins (5.8%), distal resection margins 
(5.8%), and in both resection margins (16.3%). Neural 
fiber hyperplasia was present in 37.5% of proximal 
resection margins. The pathological examination 
focused on proximal resection margins with quantitative 
evaluation of myenteric and submucosal plexitis. 
Inflammatory cell count (mastocyte, plasmocyte, 
lymphocyte, eosinophil and neutrophil granulocyte) for 
myenteric and submucosal plexuses are summarized 
in Table 2. Median severity of submucosal plexitis 
was 1 and median severity of myenteric plexitis was 
2. Submucosal plexitis was mainly constituted by 
lymphocytes (median: 2), while myenteric plexitis was 
mainly constituted by lymphocytes (median: 2) and 
plasmocytes (median: 2). Other cell types, such as 
mastocytes, eosinophils and neutrophil granulocytes 
were less frequently observed. 
We found that perianal disease [odds ratio (OR) = 
3.78, 95%CI: 1.164-12.312, P = 0.027] and female 
gender (OR = 2.21, 95%CI: 0.98-5.00, P = 0.056) 
are risk factors for postoperative relapse. Stricturing 
disease behavior (OR = 3.584, 95%CI: 1.344-9.559, 
P = 0.011) and isolated ileal disease localization (OR 
= 2.671, 95%CI: 1.033-6.910, P = 0.043) increased 
the risk of second surgery. Stricturing disease behavior 
(OR = 6.417, 95%CI: 0.999-41.212, P = 0.050) and 
ileocecal disease (OR = 6.00, 95%CI: 0.832-43.293, 
P = 0.076) also increased the risk of relapse in pre-
viously operated CD patients. 
Higher lymphocyte cell count in the submucosal 
plexus was a risk factor for surgical or clinical relapse 
(OR = 1.267, 95%CI: 1.000-1.606, P = 0.050). Mode-
rate submucosal plexitis reduced the risk of second 
surgery by 85.4% compared to severe submucosal 
plexitis (OR = 0.146, 95%CI: 0.029-0.738, P = 0.020). 
No association was revealed between postoperative 
recurrence and smoking status, postoperative prophy-
lactic treatment and the presence of myenteric plexitis 
and relapse. Figure 2 shows the survival probability 
without a second CD-related surgery and the pro-
bability without clinical recurrence.
DISCUSSION
We have demonstrated that severity of submucosal 
plexitis in proximal resection margins, perianal mani-
festation and stricturing disease behavior, as well as 
isolated ileal disease were all associated with post-
operative recurrence. Over the last few years, several 
studies focused on plexitis and its role in the post-
operative recurrence of CD. Ferrante et al[8] demon-
strated that inflammation of the myenteric plexus 
was significantly associated with postoperative CD 
endoscopic recurrence; moreover they found a positive 
correlation between the severity of the inflammatory 
infiltration of the plexus and the severity of endoscopic 
recurrence. These data are in concordance with the 
findings of recent studies: Misteli et al[9] revealed that 
severe myenteric plexitis at the proximal resection 
margin is associated with surgical resection; Ng et al[10] 
demonstrated that myenteric plexitis can be present 
in otherwise uninvolved proximal resection margins. 
Sokol et al[11] demonstrated an association between 
submucosal plexitis and early clinical recurrence; they 
found that mast cell-associated submucosal plexitis 
Figure 1  Submucosal plexitis (A) with plasma cells, eosinophil granulocyte surrounding the ganglion cell (hematoxylin-eosin staining); and myenteric 
plexitis (B) with plasma cells, neutrophil granulocyte, eosinophil granulocyte surrounding the ganglion cell (hematoxylin-eosin staining) in a Crohn’s 
disease resection specimen.
Plasma cells
Ganglion cells
Plasma cells
Eosinophil
granulocyte
Plasma cells
Ganglion cells
Eosinophil
granulocyte
Neutrophil
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A B
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in proximal resection margins is a predictor of early 
postoperative clinical recurrence. Aude et al[12] revealed 
that submucosal plexitis of > 0 eosinophils and/or 
> 6 lymphocytes in proximal resection margins and 
early surgical revision after the first ileocecal resection 
are predictive of a second surgery in CD; Lemmens 
et al[13] found that submucosal lymphocytic plexitis 
in the proximal surgical margin was significantly 
associated with a higher risk of endoscopic recurrence 
after ileocolonic resection. All these studies found that 
plexitis is more frequent in the proximal resection 
margin, but data on the prognostic value of histological 
factors in postoperative CD recurrence are conflicting. 
This is the reason why we used a comprehensive appro-
ach by analyzing all inflammatory cell types in both 
submucosal and myenteric plexuses in proximal resec-
tion margins. Data of the most severely inflamed ple­
xus were involved in the study.
Studies found myenteric plexitis in 42.5%-69.7%-88% 
of proximal surgical margins[8-10]. We could evaluate 
myenteric and submucosal plexitis of different severity 
in every sample, in accordance with Aude et al[12], 
while the rate of typical CD-lesions was low (5.7%) in 
proximal resection margins. A higher lymphocyte cell 
count in the submucosal plexus was a risk factor for 
surgical or clinical relapse (P = 0.050), while moderate 
submucosal plexitis reduced the risk of a second surgery 
by 85.4% compared to severe submucosal plexitis (P 
= 0.020), which is in accordance with other studies. 
No association was revealed between postoperative 
recurrence and the presence of myenteric plexitis.
We found no relationship between the presence of 
granulomas and clinical or surgical recurrence; however, 
we could find granulomas only in approximately half 
of the samples. A few studies found a positive asso-
ciation between the presence of granulomas and 
the likelihood of recurrence or a more aggressive 
disease process[16-18], while other studies suggested 
the opposite[19,20]. It has also been reported that the 
need for immunosuppressive therapy and surgical 
interventions were significantly higher in patients with 
granulomas.
We found no association between postoperative 
recurrence and neural hypertrophy. Ferrante et al[8] 
found that patients who had both neural hypertrophy 
in the terminal ileum and myenteric plexitis in the 
proximal resection margin had a tendency to develop 
a higher endoscopic recurrence rate compared with 
patients who only had myenteric plexitis.
Postoperative recurrence occurred in 61.5% of 
patients with a median duration of 2 years between 
the index surgery and relapse; of them 39.1% had 
surgical recurrence. Ninety-two point two percent of 
the recurrences occurred within five years. Our data 
are similar to previously published data: Surgical 
recurrence was reported in 11%-32% of patients 
at 5 years[21]. Mean disease duration for endoscopic 
relapse on the basis of the Rutgeerts score was 2.70 
years. Postoperative recurrence was divided into two 
groups on the basis of the paper of Ng et al[10] Clinical 
recurrence was defined as the presence of CD­related 
symptoms associated with radiologic or endoscopic 
findings considered severe enough to change the 
current therapy (requires steroid treatment or an 
increase in existing treatment). Surgical recurrence 
was defined as a need for further operation if the 
Median IQR, 25th to 75th
  Myenteric plexus
     Eosinophils 0 0-1
     Lymphocytes 2 1-4
     Neutrophils 0 0-0
     Plasmocytes 2 1-3
     Mastocytes 0 0-0
  Submucosal plexus
     Eosinophils 0 0-0
     Lymphocytes 2 1-3
     Neutrophils 0 0-0
     Plasmocytes 1 0-3
     Mastocytes 0 0-0
Table 2  Inflammatory cell count of histopathological findings 
(n = 104)
1.0
0.8
0.6
0.4
0.2
0.0
0           2           4           6           8           10          12
Time (yr)
Su
rv
iv
al
 p
ro
ba
bi
lit
y 
w
ith
ou
t 
a 
se
co
nd
 C
D
-r
el
at
ed
 s
ur
ge
ry
Su
rv
iv
al
 p
ro
ba
bi
lit
y 
w
ith
ou
t 
a 
cl
in
ic
al
 r
el
ap
se
1.0
0.8
0.6
0.4
0.2
0.0
0           2           4           6           8           10          12
Time (yr)
Figure 2  Shows the survival probability without a second Crohn’s disease-related surgery and the probability without clinical recurrence with the Kaplan-
Meier method. CD: Crohn’s disease.
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disease was refractory to medical treatment or new 
complications developed. 
No association was revealed between postoperative 
recurrence and preoperative or postoperative pro-
phylactic treatment. Forty-three point two percent 
of patients were on 5-aminosalicylate, 20% on cor-
ticosteroid, 68.3% on immunomodulant, and 4% on 
anti-TNF-α postoperative treatment. 5-aminosalicylic 
acid (5-ASA) has been extensively studied in the 
postoperative management of CD. Studies showed that 
the early administration of oral mesalazine following 
surgery is effective in preventing postoperative endo-
scopic recurrence in CD over a 2-year period[22] and it 
can also decrease the rate and severity of endoscopic 
recurrences[23]. In a meta­analysis, 5­ASA significantly 
reduced the risk of symptomatic relapse[24]. In a pro-
spective, open-label randomized study, azathioprine 
was more effective than mesalazine in preventing 
clinical relapse in patients with previous intestinal re-
sections[25]. These studies suggest that 5-ASA is safe 
in postoperative CD prophylaxis, even if it seems to 
provide only a small reduction in clinical and endoscopic 
recurrence[26].
Our study has certain limitations including its retro-
spective nature, although it is one of the largest series 
looking at myenteric and submucosal plexitis. As the 
course of CD may differ from one patient to another, 
many studies have looked for potential predictors of 
CD recurrence as these can modify the intensity of 
surveillance and the type of medical therapy. 
In conclusion, the presence of severe submucosal 
plexitis with lymphocytes in the proximal resection 
margin is more likely to result in postoperative rela-
pse. Postoperative assessment of plexitis could be per-
formed routinely by every pathologist in every center 
as proximal resection margins are systematically 
analyzed. This requires no special immunostaining. 
Histological analysis of the proximal resection margin 
may be useful when making a decision on early post-
operative treatment without a postoperative follow-up 
colonoscopy, thus possibly modifying the natural course 
of CD. However, further studies with a prospective 
design and a longer follow-up period are needed. 
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Crohn’s disease (CD) can affect the entire gastrointestinal tract, but the most 
commonly affected sites are the ileum and the ascending colon. More than 70% 
of all patients with CD require surgery in the course of their disease, which is not 
curative; the disease recurs in most cases. Currently, there are no reliable tools 
to predict when and in whom the disease will recur. 
Research frontiers
In the last decade, particular attention was paid to histological features to assess 
the risk of postoperative relapse (POR). Inflammatory changes in the enteric 
nervous system (myenteric and submucosal plexus) of the resection margins are 
probably the most promising factors.
Innovations and breakthroughs 
The authors confirmed the significant value of investigating the presence of 
submucosal plexitis in the proximal resection margin of ileo-colonic resection 
specimens; the severity of submucosal plexitis (higher lymphocyte cell count in 
the submucosal plexus) was a risk factor for surgical and clinical POR of CD. 
These investigations can be performed by analyzing proximal resection margins 
with routine staining. 
Applications
All available data, including ours, suggest that lymphocyte cell count plays the 
most important role in predicting the POR of CD. Routine histological analysis 
of the proximal resection margin for submucosal plexitis can be useful to 
stratify patients according to their risk to decide the need for early postoperative 
treatment. 
Terminology
POR was defined as the reappearance of lesions after complete surgical 
resection. Clinical recurrence was defined as the presence of CD-related 
symptoms associated with radiologic or endoscopic findings, considered severe 
enough to change the therapy (requires steroid treatment or an increase in 
existing treatment). Surgical recurrence was defined as a need for further 
operation.
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